VLA-4 may also bind fibronectin, which has been shown to accumulate in the brain of AD patients, so it is possible that the beneficial effect of blocking α4 integrin may also partially reflect the inhibition of adhesive interactions between these molecules19,37–39. Here, FN1 is linked to Alzheimer disease.